Lataa...
Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies
The design of human challenge studies balances scientific validity, efficiency and study safety. This Perspective explores some advantages and disadvantages of ‘low-dosage’ challenge studies, in the setting of testing second-generation vaccines against COVID-19. Compared with a conventional vaccine...
Tallennettuna:
| Julkaisussa: | Int J Infect Dis |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7881292/ https://ncbi.nlm.nih.gov/pubmed/33592338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2021.02.038 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|